KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player

SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a rare, incurable cancer. KRAS pathway alterations are frequent in human MPM but have been likely underestimated by next generation sequencing studies. ABSTRACT: Malignant pleural mesothelioma (MPM) is a rare, incurable cancer of the mesothelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Trassl, Lilith, Stathopoulos, Georgios T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454618/
https://www.ncbi.nlm.nih.gov/pubmed/36077838
http://dx.doi.org/10.3390/cancers14174303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454618/
https://www.ncbi.nlm.nih.gov/pubmed/36077838
http://dx.doi.org/10.3390/cancers14174303

Ejemplares similares